Production (Stage)
Purple Biotech Ltd
PPBT
$2.62
$0.0050.19%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | 91.51% | 53.19% | 22.88% | 19.68% | |
| Total Depreciation and Amortization | -16.67% | -7.55% | 4.35% | -4.00% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 49.13% | -254.64% | -186.22% | -605.22% | |
| Change in Net Operating Assets | -195.08% | -34.54% | 46.55% | -29.51% | |
| Cash from Operations | 59.57% | 23.88% | 16.19% | -18.22% | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -48.65% | -56.28% | -98.07% | -99.07% | |
| Cash from Investing | -48.65% | -56.06% | -97.52% | -99.07% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -14.29% | -9.52% | -7.14% | -2.44% | |
| Issuance of Common Stock | 109,075.00% | 16.05% | -5.32% | -97.85% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -108.87% | -10.39% | 31.46% | 7,750.00% | |
| Cash from Financing | -7.23% | 17.98% | 1.52% | 4,670.79% | |
| Foreign Exchange rate Adjustments | -100.00% | 78.26% | -104.00% | -42.68% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 419.19% | 26.06% | -165.72% | -115.55% | |